For pharmacists, from Drug Topics: Clinic news stories - Drug Topics

ADVERTISEMENT

Clinical News
For pharmacists, from Drug Topics: News and features for pharmacists about clinical trials, newly approved drugs, and new practices in clinical pharmacy

Opioid analgesic on market for cancer pain management

March 15, 2010

An FDA-approved oral transmucosal fentanyl citrate, an opioid analgesic for cancer pain management, is being launched by Mallinckrodt Inc., a Covidien company.

FDA curbs LABA use for asthma

March 15, 2010

FDA recommended drastic changes limiting the way long-acting beta2-adrenergic agonists are used to treat asthma.

Opioid REMS may require pharmacist certification

March 15, 2010

REMS for opioids may present some tough challenges for pharmacists.

Investigational drug may boost survival for certain prostate cancer patients

March 15, 2010

Cabazitaxel, an investigational compound under development by Sanofi-aventis, plus prednisone/prednisolone, is associated with overall survival and progression-free survival in patients with metastatic (advanced) hormone-refractory prostate cancer whose disease advanced after treatment with docetaxel-based chemotherapy.

Injection pen will aid those with growth hormone-related conditions

March 15, 2010

Norditropin FlexPro (somatropin [rDNA origin] injection, Novo Nordisk), a pre-filled injection pen for use in children and adults with growth hormone disorders, will be available this spring.

Medications donated to Kansas clinics

March 15, 2010

More than $600,000 of unused medications were donated to Kansas clinics last year.

Rep. Marion Berry garners NACDS leadership award

March 15, 2010

The National Association of Chain Drug Stores (NACDS) awarded Rep. Marion Berry the NACDS Congressional Leadership Award for his ongoing support of pharmacy.

IOM calls for research on vaccination delivery sites

March 15, 2010

The Institute of Medicine says more research is necessary comparing the advantages of different sites for vaccination.

First direct thrombin inhibitor cleared for DVT prevention

March 15, 2010

The FDA-approved Iprivask (desirudin for injection, Canyon Pharmaceuticals), now available, marks the first direct thrombin inhibitor (DTI) OK'd for the prevention of deep vein thrombosis (DVT).

Drug Topics Issue
Drug Topics is a monthly news magazine, guided by a board of pharmacy leaders, reporting on all phases of community, retail, and health-system issues and trends. We cover managed care and professional, national, and state activities as well as new therapies involving prescription and OTC drugs.
ARCHIVES | RSS | E-NEWS | DIGITAL EDITION

ADVERTISEMENT

ADVERTISEMENT

Survey
Which pharmacists' membership organization best represents your concerns?
Local
Regional
State
National
Specialized interest group
Other
None
Local
6%
Regional
0%
State
35%
National
24%
Specialized interest group
6%
Other
0%
None
29%
View Results

Modern Medicine logoDrug Topics archives are now available on ModernMedicine.com, a new online resource designed to meet the evolving needs of physicians.
Register now (it's free and quick) or Find out more.

Keep visiting Drug Topics for fresh content, news, opinions, editor's blogs and more.

ADVERTISEMENT

Click here